SRL
ADMA icon

Scientech Research LLC’s ADMA Biologics ADMA Stock Holding History

Scientech Research LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
+23,756
New +$375K 0.18% 222
2025
Q4 		– Sell
-33,862
Closed -$496K – 485
2025
Q3 		$496K Sell
33,862
-3,954
-10% -$67.8K 0.17% 259
2025
Q2 		$689K Buy
+37,816
New +$771K 0.17% 253

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Scientech Research LLC's ADMA Position: Q1 2026 in Review

Scientech Research LLC opened a new position in ADMA Biologics (ADMA) in Q1 2026: 23,756 shares worth $214K. The stake represents 0.18% of the portfolio and ranks #222 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in ADMA as recently as Q3 2025.

Scientech Research LLC first reported a position in ADMA in Q2 2025 and has held it in 3 quarters since. The position peaked at $689K in Q2 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Scientech Research LLC held 23,756 shares of ADMA Biologics worth $214K as of Q1 2026.
  • ADMA Biologics was a new Scientech Research LLC position in Q1 2026.
  • ADMA Biologics made up 0.18% of Scientech Research LLC's portfolio in Q1 2026, its #222 holding.
  • Scientech Research LLC first reported a position in ADMA Biologics in Q2 2025 and has held it in 3 quarters since.
  • Scientech Research LLC's ADMA Biologics position peaked at $689K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.